Applications of Machine Learning in Computer-Aided Drug Discovery

SM Bargeen Alam Turzo,Eric R. Hantz,Steffen Lindert

DOI: https://doi.org/10.1017/qrd.2022.12

2022-09-02

QRB Discovery

Abstract://static.cambridge.org/content/id/urn%3Acambridge.org%3Aid%3Aarticle%3AS2633289222000126/resource/name/firstPage-S2633289222000126a.jpg

What problem does this paper attempt to address?

Machine Learning Applications in Drug Discovery

Sadettin Y Ugurlu

DOI: https://doi.org/10.26434/chemrxiv-2024-1zwr6-v2

2024-09-26

Abstract:Integrating machine learning (ML) into drug discovery has ushered in a new era of innovation, dramatically enhancing the efficiency and precision of identifying and developing new therapeutics. This review provides a comprehensive analysis of the current applications of machine learning in drug discovery, focusing on its transformative impact across various stages of the drug development pipeline. We delve into key ML methodologies, including supervised and unsupervised learning, neural networks, and reinforcement learning, examining their underlying principles and specific contributions to drug discovery processes. By exploring case studies and recent advancements, this review illustrates how ML algorithms have been utilized to predict drug-target interactions, optimize drug design, and streamline clinical trial processes. Furthermore, we discuss the challenges and limitations of implementing ML techniques in this field and highlight emerging trends and future directions. This review aims to offer researchers a thorough understanding of ML's potential to revolutionize drug discovery and equip them with the insights needed to leverage these technologies effectively.

Chemistry
Applications of machine learning in drug discovery and development

Jessica Vamathevan,Dominic Clark,Paul Czodrowski,Ian Dunham,Edgardo Ferran,George Lee,Bin Li,Anant Madabhushi,Parantu Shah,Michaela Spitzer,Shanrong Zhao

DOI: https://doi.org/10.1038/s41573-019-0024-5

IF: 112.288

2019-04-11

Nature Reviews Drug Discovery

Abstract:Drug discovery and development pipelines are long, complex and depend on numerous factors. Machine learning (ML) approaches provide a set of tools that can improve discovery and decision making for well-specified questions with abundant, high-quality data. Opportunities to apply ML occur in all stages of drug discovery. Examples include target validation, identification of prognostic biomarkers and analysis of digital pathology data in clinical trials. Applications have ranged in context and methodology, with some approaches yielding accurate predictions and insights. The challenges of applying ML lie primarily with the lack of interpretability and repeatability of ML-generated results, which may limit their application. In all areas, systematic and comprehensive high-dimensional data still need to be generated. With ongoing efforts to tackle these issues, as well as increasing awareness of the factors needed to validate ML approaches, the application of ML can promote data-driven decision making and has the potential to speed up the process and reduce failure rates in drug discovery and development.

pharmacology & pharmacy,biotechnology & applied microbiology
Machine Learning Approaches and their Applications in Drug Discovery and Design

Sonal Priya,Garima Tripathi,Dev Bukhsh Singh,Priyanka Jain,Abhijeet Kumar

DOI: https://doi.org/10.1111/cbdd.14057

2022-04-15

Abstract:Machine learning approaches are used in various areas of Chemoinformatics such as reaction representation, de novo designing, structure determination, descriptor analysis, chemometrics, etc.This review is focused on several machine learning approaches used in chemoinformatics. Machine learning approaches provide tools and algorithms to improve drug discovery. Many physicochemical properties of drugs like toxicity, absorption, drug‐drug interaction, carcinogenesis, and distribution have been effectively modeled by QSAR techniques. Machine learning is a subset of artificial intelligence and this technique has shown tremendous potential in the field of drug discovery. Techniques discussed in this review are capable of modeling non‐linear datasets, as well as big data of increasing depth and complexity. Various machine learning‐based approaches are being used for drug target prediction, modeling the structure of drug target, binding site prediction, ligand‐based similarity searching, de novo designing of ligands with desired properties, developing scoring functions for molecular docking, building QSAR model for biological activity prediction, and prediction of pharmacokinetic and pharmacodynamic properties of ligands. In recent years, these predictive tools and models have achieved good accuracy. By the use of more related input data, relevant parameters, and appropriate algorithms, the accuracy of these predictions can be further improved.

biochemistry & molecular biology,chemistry, medicinal
Application of Artificial Intelligence and Machine Learning in Drug Discovery and Development

Madhukiran Parvathaneni,Abduselam K. Awol,Monika Kumari,Ke Lan,Manisha Lingam

DOI: https://doi.org/10.22270/jddt.v13i1.5867

2023-01-15

Journal of Drug Delivery and Therapeutics

Abstract:Drug discovery has traditionally been a time consuming and expensive endeavor. Additionally, drugs weren’t as effectively designed as those that are being predicted and developed through AI and ML today. Machine learning is a form of artificial intelligence that develops and evolves based on experience (similarly to the human mind), and is more recently being utilized in drug discovery and design. The integration of AI and ML into the drug discovery and development process has allowed for higher target precision, lower toxicity, and better dosage formulations. AI more generally has been introduced to and has been leveraged at, each step of drug development, including target identification and validation, hit identification, as well as hit to lead optimization, and has been key in shortening the previously lengthy drug screening process. AI and ML has also been applied downstream in drug formulation where it has maximized resource utilization and is allowing for web-based 3D printing of drugs. Application of AI in the drug development process has also been extended to the modeling of novel drug-like compounds to predict their ADMET properties. This review will address the stages of drug discovery and development in which the application of AI and ML modeling has altered the traditional development of drugs. Keywords: Drug discovery, machine learning, artificial intelligence, computational drug development.
Application of Machine Learning in Drug Discovery and Development Lifecycle

Geerisha Jain

DOI: https://doi.org/10.22161/ijmpd.6.6.4

2022-01-01

Abstract:Machine learning and Artificial Intelligence have significantly advanced in recent years owing to their potential to considerably increase the quality of life while reducing human workload. The paper demonstrates how AI and ML are used in the drug development process to shorten and enhance the overall timeline. It contains pertinent information on a variety of Machine Learning approaches and algorithms that are used across the whole drug development process to speed up research, save expenses, and reduce risks related to clinical trials. A range of QSAR analysis, hit finding, and de novo drug design applications are used in the pharmaceutical industry to enhance decision-making. As technologies like high-throughput screening and computation analysis of databases used for lead and target identification and development create and integrate vast volumes of data, machine learning and deep learning have grown in importance. It has also been emphasized how these cognitive models and tools may be used in lead creation, optimization, and thorough virtual screening. In this paper, problem statements and the corresponding state-of-the-art models have been considered for target validation, prognostic biomarkers, and digital pathology. Machine Learning models play a vital role in the various operations related to clinical trials embracing protocol optimization, participant management, data analysis and storage, clinical trial data verification, and surveillance. Post-development drug monitoring and unique industrially prevalent ML applications of pharmacovigilance have also been discussed. As a result, the goal of this study is to investigate the machine learning and deep learning algorithms utilised across the drug development lifecycle as well as the supporting techniques that have the potential to be useful.
Machine learning directed drug formulation development

Pauric Bannigan,Matteo Aldeghi,Zeqing Bao,Florian Häse,Alán Aspuru-Guzik,Christine Allen

DOI: https://doi.org/10.1016/j.addr.2021.05.016

Abstract:Machine learning (ML) has enabled ground-breaking advances in the healthcare and pharmaceutical sectors, from improvements in cancer diagnosis, to the identification of novel drugs and drug targets as well as protein structure prediction. Drug formulation is an essential stage in the discovery and development of new medicines. Through the design of drug formulations, pharmaceutical scientists can engineer important properties of new medicines, such as improved bioavailability and targeted delivery. The traditional approach to drug formulation development relies on iterative trial-and-error, requiring a large number of resource-intensive and time-consuming in vitro and in vivo experiments. This review introduces the basic concepts of ML-directed workflows and discusses how these tools can be used to aid in the development of various types of drug formulations. ML-directed drug formulation development offers unparalleled opportunities to fast-track development efforts, uncover new materials, innovative formulations, and generate new knowledge in drug formulation science. The review also highlights the latest artificial intelligence (AI) technologies, such as generative models, Bayesian deep learning, reinforcement learning, and self-driving laboratories, which have been gaining momentum in drug discovery and chemistry and have potential in drug formulation development.
Lessons learnt from machine learning in early stages of drug discovery

Claudio N. Cavasotto,Juan I. Di Filippo,Valeria Scardino

DOI: https://doi.org/10.1080/17460441.2024.2354279

2024-05-12

Expert Opinion on Drug Discovery

Abstract:KEYWORDS: With the promise of a big leap, the field of Drug Discovery (DD) seems to have been permeated by Machine Learning (ML); it is not unreasonable to think that for every single 'classical' computational method within DD, there exists an ML-based counterpart; namely, for docking, Molecular Dynamics (MD), protein modeling, etc. Furthermore, the amount of money being invested for ML in DD is growing steadily. Evidently, ML methods have come to stay, and, in our opinion, they will be a valuable aid in accelerating the drug discovery pipeline.

pharmacology & pharmacy
Machine learning in preclinical drug discovery

Denise B. Catacutan,Jeremie Alexander,Autumn Arnold,Jonathan M. Stokes

DOI: https://doi.org/10.1038/s41589-024-01679-1

IF: 14.8

2024-07-20

Nature Chemical Biology

Abstract:Drug-discovery and drug-development endeavors are laborious, costly and time consuming. These programs can take upward of 12 years and cost US $2.5 billion, with a failure rate of more than 90%. Machine learning (ML) presents an opportunity to improve the drug-discovery process. Indeed, with the growing abundance of public and private large-scale biological and chemical datasets, ML techniques are becoming well positioned as useful tools that can augment the traditional drug-development process. In this Perspective, we discuss the integration of algorithmic methods throughout the preclinical phases of drug discovery. Specifically, we highlight an array of ML-based efforts, across diverse disease areas, to accelerate initial hit discovery, mechanism-of-action (MOA) elucidation and chemical property optimization. With advances in the application of ML across diverse therapeutic areas, we posit that fully ML-integrated drug-discovery pipelines will define the future of drug-development programs.

biochemistry & molecular biology
Machine Learning Empowering Drug Discovery: Applications, Opportunities and Challenges

Xin Qi,Yuanchun Zhao,Zhuang Qi,Siyu Hou,Jiajia Chen

DOI: https://doi.org/10.3390/molecules29040903

IF: 4.6

2024-02-19

Molecules

Abstract:Drug discovery plays a critical role in advancing human health by developing new medications and treatments to combat diseases. How to accelerate the pace and reduce the costs of new drug discovery has long been a key concern for the pharmaceutical industry. Fortunately, by leveraging advanced algorithms, computational power and biological big data, artificial intelligence (AI) technology, especially machine learning (ML), holds the promise of making the hunt for new drugs more efficient. Recently, the Transformer-based models that have achieved revolutionary breakthroughs in natural language processing have sparked a new era of their applications in drug discovery. Herein, we introduce the latest applications of ML in drug discovery, highlight the potential of advanced Transformer-based ML models, and discuss the future prospects and challenges in the field.

chemistry, multidisciplinary,biochemistry & molecular biology
What are the current challenges for machine learning in drug discovery and repurposing?

Tero Aittokallio

DOI: https://doi.org/10.1080/17460441.2022.2050694

2022-03-08

Expert Opinion on Drug Discovery

Abstract:Machine learning (ML) approaches have been increasingly adopted for computer-assisted drug discovery in the recent years. This rapid progress is mostly due to the large-scale data sets available for ML model training, along with the development of deep learning (DL) and other artificial intelligence (AI) approaches that enable an integrated use of heterogeneous compound and target data, ranging from chemical structure to biochemical, in vitro, in vivo, and clinical endpoints for treatment response modeling. Exciting opportunities to apply ML and AI methods occur in all stages of drug discovery and development, including target identification and validation, prediction of molecular structure and function, and compound screening and optimization [1]. Based on high-quality training data, supervised learning and feature selection offers a systematic means for identification of predictive biomarkers for precision medicine; for instance, using clinical data, such predictive approaches may provide real-word evidence of treatment responses for designing marker-based trials and improving patient selection. In particular, cancer research and precision oncology has witnessed in the past few years an enormous progress in the application of ML to cancer detection and diagnosis, identification of new targets for anticancer drug discovery and repurposing, along with prediction of treatment outcomes for cancer patients [2].

pharmacology & pharmacy
Application of Deep Learning Neural Networks in Computer-aided Drug Discovery: A Review

Jay Shree Mathivanan,Victor Violet Dhayabaran,Mary Rajathei David,Muthugobal Bagayalakshmi Karuna Nidhi,Karuppasamy Muthuvel Prasath,Suvaiyarasan Suvaithenamudhan

DOI: https://doi.org/10.2174/0115748936276510231123121404

2024-01-23

Current Bioinformatics

Abstract:Abstract: Computer-aided drug design has an important role in drug development and design. It has become a thriving area of research in the pharmaceutical industry to accelerate the drug discovery process. Deep learning, a subdivision of artificial intelligence, is widely applied to advance new drug development and design opportunities. This article reviews the recent technology that uses deep learning techniques to ameliorate the understanding of drug-target interactions in computer-aided drug discovery based on the prior knowledge acquired from various literature. In general, deep learning models can be trained to predict the binding affinity between the protein-ligand complexes and protein structures or generate protein-ligand complexes in structure-based drug discovery. In other words, artificial neural networks and deep learning algorithms, especially graph convolutional neural networks and generative adversarial networks, can be applied to drug discovery. Graph convolutional neural network effectively captures the interactions and structural information between atoms and molecules, which can be enforced to predict the binding affinity between protein and ligand. Also, the ligand molecules with the desired properties can be generated using generative adversarial networks.

biochemical research methods,mathematical & computational biology
A Systematic Literature Review of the Current Status and Future Prospects of Machine Learning Methods and Techniques Applied to Novel Drug Discovery

Ali Abdelkrim,Abdelkrim Bouramoul,Imene Zenbout

DOI: https://doi.org/10.4018/ijoci.312223

2022-10-21

International Journal of Organizational and Collective Intelligence

Abstract:Drug development is the hardest phase for the pharmaceutical industry because it is extremely costly and time consuming. Though, due to the growing demand to produce safe and innovative medicines faster and more cost-effectively, the scientific community changed its objective into enhancing the lead identification and the lead optimization at the early discovery phase. This could be achieved using recent intelligent technologies that allow virtual screening as well as quantitative structure-activity relationship (QSAR) modeling to define the possible relationships between chemical compounds and biological activities. Among recent technologies, artificial intelligence (AI) has been introduced as a powerful solution to address problems related to drug discovery and development. In particular, machine learning (ML) has been meaningfully instrumental in the production of new drug candidates. In this work, we review the fundamental principles of machine learning algorithms, study and discuss their application and current issues in drug development.
Machine learning for target discovery in drug development

Tiago Rodrigues,Gonçalo J.L. Bernardes

DOI: https://doi.org/10.1016/j.cbpa.2019.10.003

IF: 8.972

2020-06-01

Current Opinion in Chemical Biology

Abstract:The discovery of macromolecular targets for bioactive agents is currently a bottleneck for the informed design of chemical probes and drug leads. Typically, activity profiling against genetically manipulated cell lines or chemical proteomics is pursued to shed light on their biology and deconvolute drug-target networks. By taking advantage of the ever-growing wealth of publicly available bioactivity data, learning algorithms now provide an attractive means to generate statistically motivated research hypotheses and thereby prioritize biochemical screens. Here, we highlight recent successes in machine intelligence for target identification and discuss challenges and opportunities for drug discovery.

biochemistry & molecular biology,biophysics
A Comprehensive Review on Machine Learning and Deep Learning Methods in Drug Discovery

Sneha Khaire,Pawan Bhaladhare

DOI: https://doi.org/10.17762/ijritcc.v10i10.5728

2022-10-31

International Journal on Recent and Innovation Trends in Computing and Communication

Abstract:Due to its ability to drastically cut the time and money required to develop new medicines, artificial intelligence (AI) based drug discovery has recently attracted a lot of attention. The fields of drug research and development have made use of machine learning (ML) and deep learning (DL) technologies to develop new medication prospects. Machine learning and deep learning-based techniques are emerging at every level of the drug development process as a result of the proliferation of drug-related data. Preclinical testing of a target of interest has proven to be particularly tough for pharmaceutical chemists, who face significant challenges in selecting and developing effective drugs. Machine learning and deep learning algorithms are now extensively used in approaches for generating therapeutic targets and innovative medication development in order to increase the accuracy, efficiency, and quality of created outputs. This review focuses on the application of machine learning and deep learning algorithms in drug development, as well as related approaches. We'll look at the approaches and methods that seem most promising in terms of their potential impact.
Deep learning tools for advancing drug discovery and development

Sagorika Nag,Anurag T. K. Baidya,Abhimanyu Mandal,Alen T. Mathew,Bhanuranjan Das,Bharti Devi,Rajnish Kumar

DOI: https://doi.org/10.1007/s13205-022-03165-8

IF: 2.893

2022-04-09

3 Biotech

Abstract:A few decades ago, drug discovery and development were limited to a bunch of medicinal chemists working in a lab with enormous amount of testing, validations, and synthetic procedures, all contributing to considerable investments in time and wealth to get one drug out into the clinics. The advancements in computational techniques combined with a boom in multi-omics data led to the development of various bioinformatics/pharmacoinformatics/cheminformatics tools that have helped speed up the drug development process. But with the advent of artificial intelligence (AI), machine learning (ML) and deep learning (DL), the conventional drug discovery process has been further rationalized. Extensive biological data in the form of big data present in various databases across the globe acts as the raw materials for the ML/DL-based approaches and helps in accurate identifications of patterns and models which can be used to identify therapeutically active molecules with much fewer investments on time, workforce and wealth. In this review, we have begun by introducing the general concepts in the drug discovery pipeline, followed by an outline of the fields in the drug discovery process where ML/DL can be utilized. We have also introduced ML and DL along with their applications, various learning methods, and training models used to develop the ML/DL-based algorithms. Furthermore, we have summarized various DL-based tools existing in the public domain with their application in the drug discovery paradigm which includes DL tools for identification of drug targets and drug–target interaction such as DeepCPI, DeepDTA, WideDTA, PADME DeepAffinity, and DeepPocket. Additionally, we have discussed various DL-based models used in protein structure prediction, de novo design of new chemical scaffolds, virtual screening of chemical libraries for hit identification, absorption, distribution, metabolism, excretion, and toxicity (ADMET) prediction, metabolite prediction, clinical trial design, and oral bioavailability prediction. In the end, we have tried to shed light on some of the successful ML/DL-based models used in the drug discovery and development pipeline while also discussing the current challenges and prospects of the application of DL tools in drug discovery and development. We believe that this review will be useful for medicinal and computational chemists searching for DL tools for use in their drug discovery projects.

biotechnology & applied microbiology
Machine Learning in Antibacterial Drug Design

Marko Jukič,Urban Bren

DOI: https://doi.org/10.3389/fphar.2022.864412

IF: 5.6

2022-05-04

Frontiers in Pharmacology

Abstract:Advances in computer hardware and the availability of high-performance supercomputing platforms and parallel computing, along with artificial intelligence methods are successfully complementing traditional approaches in medicinal chemistry. In particular, machine learning is gaining importance with the growth of the available data collections. One of the critical areas where this methodology can be successfully applied is in the development of new antibacterial agents. The latter is essential because of the high attrition rates in new drug discovery, both in industry and in academic research programs. Scientific involvement in this area is even more urgent as antibacterial drug resistance becomes a public health concern worldwide and pushes us increasingly into the post-antibiotic era. In this review, we focus on the latest machine learning approaches used in the discovery of new antibacterial agents and targets, covering both small molecules and antibacterial peptides. For the benefit of the reader, we summarize all applied machine learning approaches and available databases useful for the design of new antibacterial agents and address the current shortcomings.

pharmacology & pharmacy
Artificial Intelligence and Machine Learning Technology Driven Modern Drug Discovery and Development

Chayna Sarkar,Biswadeep Das,Vikram Singh Rawat,Julie Birdie Wahlang,Arvind Nongpiur,Iadarilang Tiewsoh,Nari M Lyngdoh,Debasmita Das,Manjunath Bidarolli,Hannah Theresa Sony

DOI: https://doi.org/10.3390/ijms24032026

2023-01-19

Abstract:The discovery and advances of medicines may be considered as the ultimate relevant translational science effort that adds to human invulnerability and happiness. But advancing a fresh medication is a quite convoluted, costly, and protracted operation, normally costing USD ~2.6 billion and consuming a mean time span of 12 years. Methods to cut back expenditure and hasten new drug discovery have prompted an arduous and compelling brainstorming exercise in the pharmaceutical industry. The engagement of Artificial Intelligence (AI), including the deep-learning (DL) component in particular, has been facilitated by the employment of classified big data, in concert with strikingly reinforced computing prowess and cloud storage, across all fields. AI has energized computer-facilitated drug discovery. An unrestricted espousing of machine learning (ML), especially DL, in many scientific specialties, and the technological refinements in computing hardware and software, in concert with various aspects of the problem, sustain this progress. ML algorithms have been extensively engaged for computer-facilitated drug discovery. DL methods, such as artificial neural networks (ANNs) comprising multiple buried processing layers, have of late seen a resurgence due to their capability to power automatic attribute elicitations from the input data, coupled with their ability to obtain nonlinear input-output pertinencies. Such features of DL methods augment classical ML techniques which bank on human-contrived molecular descriptors. A major part of the early reluctance concerning utility of AI in pharmaceutical discovery has begun to melt, thereby advancing medicinal chemistry. AI, along with modern experimental technical knowledge, is anticipated to invigorate the quest for new and improved pharmaceuticals in an expeditious, economical, and increasingly compelling manner. DL-facilitated methods have just initiated kickstarting for some integral issues in drug discovery. Many technological advances, such as "message-passing paradigms", "spatial-symmetry-preserving networks", "hybrid de novo design", and other ingenious ML exemplars, will definitely come to be pervasively widespread and help dissect many of the biggest, and most intriguing inquiries. Open data allocation and model augmentation will exert a decisive hold during the progress of drug discovery employing AI. This review will address the impending utilizations of AI to refine and bolster the drug discovery operation.
Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery

Xin Yang,Yifei Wang,Ryan Byrne,Gisbert Schneider,Shengyong Yang

DOI: https://doi.org/10.1021/acs.chemrev.8b00728

IF: 62.1

2019-07-11

Chemical Reviews

Abstract:Artificial intelligence (AI), and, in particular, deep learning as a subcategory of AI, provides opportunities for the discovery and development of innovative drugs. Various machine learning approaches have recently (re)emerged, some of which may be considered instances of domain-specific AI which have been successfully employed for drug discovery and design. This review provides a comprehensive portrayal of these machine learning techniques and of their applications in medicinal chemistry. After introducing the basic principles, alongside some application notes, of the various machine learning algorithms, the current state-of-the art of AI-assisted pharmaceutical discovery is discussed, including applications in structure- and ligand-based virtual screening, de novo drug design, physicochemical and pharmacokinetic property prediction, drug repurposing, and related aspects. Finally, several challenges and limitations of the current methods are summarized, with a view to potential future directions for AI-assisted drug discovery and design.
Novel Big Data-Driven Machine Learning Models for Drug Discovery Application

Vishnu Sripriya Akondi,Vineetha Menon,Jerome Baudry,Jana Whittle

DOI: https://doi.org/10.3390/molecules27030594

IF: 4.6

2022-01-18

Molecules

Abstract:Most contemporary drug discovery projects start with a ‘hit discovery’ phase where small chemicals are identified that have the capacity to interact, in a chemical sense, with a protein target involved in a given disease. To assist and accelerate this initial drug discovery process, ’virtual docking calculations’ are routinely performed, where computational models of proteins and computational models of small chemicals are evaluated for their capacities to bind together. In cutting-edge, contemporary implementations of this process, several conformations of protein targets are independently assayed in parallel ‘ensemble docking’ calculations. Some of these protein conformations, a minority of them, will be capable of binding many chemicals, while other protein conformations, the majority of them, will not be able to do so. This fact that only some of the conformations accessible to a protein will be ’selected’ by chemicals is known as ’conformational selection’ process in biology. This work describes a machine learning approach to characterize and identify the properties of protein conformations that will be selected (i.e., bind to) chemicals, and classified as potential binding drug candidates, unlike the remaining non-binding drug candidate protein conformations. This work also addresses the class imbalance problem through advanced machine learning techniques that maximize the prediction rate of potential protein molecular conformations for the test case proteins ADORA2A (Adenosine A2a Receptor) and OPRK1 (Opioid Receptor Kappa 1), and subsequently reduces the failure rates and hastens the drug discovery process.

chemistry, multidisciplinary,biochemistry & molecular biology
Deep Learning in Virtual Screening: Recent Applications and Developments

Talia B Kimber,Yonghui Chen,Andrea Volkamer,Talia B. Kimber

DOI: https://doi.org/10.3390/ijms22094435

IF: 5.6

2021-04-23

International Journal of Molecular Sciences

Abstract:Drug discovery is a cost and time-intensive process that is often assisted by computational methods, such as virtual screening, to speed up and guide the design of new compounds. For many years, machine learning methods have been successfully applied in the context of computer-aided drug discovery. Recently, thanks to the rise of novel technologies as well as the increasing amount of available chemical and bioactivity data, deep learning has gained a tremendous impact in rational active compound discovery. Herein, recent applications and developments of machine learning, with a focus on deep learning, in virtual screening for active compound design are reviewed. This includes introducing different compound and protein encodings, deep learning techniques as well as frequently used bioactivity and benchmark data sets for model training and testing. Finally, the present state-of-the-art, including the current challenges and emerging problems, are examined and discussed.

biochemistry & molecular biology,chemistry, multidisciplinary

Applications of Machine Learning in Computer-Aided Drug Discovery

Machine Learning Applications in Drug Discovery

Applications of machine learning in drug discovery and development

Machine Learning Approaches and their Applications in Drug Discovery and Design

Application of Artificial Intelligence and Machine Learning in Drug Discovery and Development

Application of Machine Learning in Drug Discovery and Development Lifecycle

Machine learning directed drug formulation development

Lessons learnt from machine learning in early stages of drug discovery

Machine learning in preclinical drug discovery

Machine Learning Empowering Drug Discovery: Applications, Opportunities and Challenges

What are the current challenges for machine learning in drug discovery and repurposing?

Application of Deep Learning Neural Networks in Computer-aided Drug Discovery: A Review

A Systematic Literature Review of the Current Status and Future Prospects of Machine Learning Methods and Techniques Applied to Novel Drug Discovery

Machine learning for target discovery in drug development

A Comprehensive Review on Machine Learning and Deep Learning Methods in Drug Discovery

Deep learning tools for advancing drug discovery and development

Machine Learning in Antibacterial Drug Design

Artificial Intelligence and Machine Learning Technology Driven Modern Drug Discovery and Development

Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery

Novel Big Data-Driven Machine Learning Models for Drug Discovery Application

Deep Learning in Virtual Screening: Recent Applications and Developments